维生素D在结核性硬化症复杂相关的瘤中
1Department of Pediatrics, Social Welfare Aiseikai, Suihoen, Japan.
Frontiers in pediatrics
|June 7, 2024
概括
1,25-二氧维生素D3 (1,25-D) 作为结核硬化综合体 (TSC) 瘤的辅助疗法具有前景,可能增强mTOR抑制剂的疗效并减少副作用. 需要进一步的体外研究来证实其益处.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 发展生物学 发展生物学
- 神经科学是一个神经科学.
背景情况:
- 哺乳动物向的拉巴胺素抑制剂 (mTORi) 用于儿科结核硬化综合体 (TSC) 相关的瘤,但在停止后可能导致副作用和瘤回归.
- 需要组合疗法来提高mTORi的疗效,并尽量减少TSC患者的不良影响.
- 细胞和癌症有共同的途径,如血管生成,细胞生长和增殖,这表明潜在的治疗重叠.
研究的目的:
- 探索1,25-二氧维生素D3 (1,25-D) 作为TSC相关瘤的潜在辅助或替代疗法.
- 研究维生素D受体介导信号作为TSC中的药物点的作用.
- 通过实验室研究评估1,25-D在TSC相关瘤,大脑发育和精神疾病中的疗效.
主要方法:
- 关于mTOR抑制剂,TSC和癌症中的维生素D信号的文献综述.
- 分析TSC和癌症之间共享的分子机制,包括血管新生,细胞生长和增殖.
- 建议进行体外研究,以评估TSC模型中的1,25-D疗效.
主要成果:
- 1,25-二氧维生素D3 (1,25-D) 具有与TSC病理生理学相关的抗癌特性.
- 维生素D受体介导的信号传递是一种潜在的治疗点,受表观遗传修饰的影响.
- 在TSC和癌症之间共享的细胞机制表明1,25-D可能是有效的.
结论:
- 1,25-二氧维生素D3 (1,25-D) 是一个有前途的候选人辅助或替代疗法在TSC.
- 准维生素D信号传递可能为管理TSC相关瘤和相关并发症提供一种新的方法.
- 在体外研究对于验证1,25-D在TSC中的治疗潜力至关重要.
相关概念视频
Connective Tissue Cell Types
3.2K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K

![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
